AW

Aayush Wadhwa

Active Director Director DIN 11292417
DIN 11292417 First appointment Sep 2025
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Aayush Wadhwa

Data last updated:

Aayush Wadhwa is a Director at Nuvesa Pharma Private Limited (since 2025). Nuvesa Pharma Private Limited reported revenue of ₹1.13 Cr (FY 2025).

DIN 11292417
Primary Designation Director
First Appointment 11 Sep 2025
Oldest Company Age 2 yrs
Largest company Nuvesa Pharma Private Limited · ₹1.13 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nuvesa Pharma Private Limited U46497HR2024PTC122276
Director11 Sep 20252024₹1.13 Cr (FY 2025)Active

Board colleagues of Aayush Wadhwa

NameDINCompanyDesignation
Neetu Saini10658086Nuvesa Pharma Private LimitedDirector
Sanjeev Kumar07450119Nuvesa Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nuvesa Pharma Private Limited
Premium access

Shareholding and investment profile for Aayush Wadhwa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aayush Wadhwa

Aayush Wadhwa currently holds 1 directorship: Nuvesa Pharma Private Limited (Director, since 11 Sep 2025, revenue ₹1.13 Cr (FY 2025)).

Aayush Wadhwa was first appointed on 11 Sep 2025 as Director at Nuvesa Pharma Private Limited.

The current boards of Aayush Wadhwa's companies include Neetu Saini (Nuvesa Pharma Private Limited), Sanjeev Kumar (Nuvesa Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available